Oxford/AstraZeneca vaccine results face growing scrutiny
By The Guardian / November 27, 2020 / marketsanity.com / Article Link
One US analyst wrote that "we believe that this product will never be licensed in the US" and alleged the company had tried to "embellish" the results.